Charles River Laboratories International Inc (NYSE:CRL)
| 144.71 Delayed Data As of Dec 09 |  -1.52 / -1.04%Today’s Change | 103.00 Today|||52-Week Range 149.07 | +27.86% Year-to-Date |
Latest CRL News | Press Releases
No recent news for Charles River Laboratories International Inc.
Today’s Trading
| Previous close | 146.23 |
| Today’s open | 146.79 |
| Day’s range | 143.18 - 146.79 |
| Volume | 355,977 |
| Average volume (3 months) | 323,411 |
| Market cap | $7.1B |
Data as of 6:30pm ET, 12/09/2019
Growth & Valuation
| Earnings growth (last year) | +81.59% |
| Earnings growth (this year) | +8.62% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +21.99% |
| P/E ratio | 30.9 |
| Price/Sales | 2.42 |
| Price/Book | 5.35 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRAHPRA Health Sciences ... | -1.80 | -1.65% |
| AMRNAmarin Corporation P... | +0.12 | +0.53% |
| SYNHSyneos Health Inc | -0.22 | -0.40% |
| ICLRICON PLC | -1.67 | -1.03% |
Data as of 4:00pm ET, 12/09/2019
Financials
| Next reporting date | February 11, 2020 |
| EPS forecast (this quarter) | $1.83 |
| Annual revenue (last year) | $2.3B |
| Annual profit (last year) | $226.4M |
| Net profit margin | 9.92% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters Wilmington, Massachusetts |
Forecasts
